<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5461679</article-id><article-id pub-id-type="publisher-id">1708</article-id><article-id pub-id-type="doi">10.1186/s13054-017-1708-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Fourth Surviving Sepsis Campaign&#x02019;s hemodynamic recommendations: a step forward or a return to chaos?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>Glenn</given-names></name><address><email>glennguru@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5748-7820</contrib-id><name><surname>Teboul</surname><given-names>Jean-Louis</given-names></name><address><phone>+33145213547</phone><email>jean-louis.teboul@aphp.fr</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 0406</institution-id><institution-id institution-id-type="GRID">grid.7870.8</institution-id><institution>Departamento de Medicina Intensiva, Facultad de Medicina, </institution><institution>Pontificia Universidad Cat&#x000f3;lica de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 7253</institution-id><institution-id institution-id-type="GRID">grid.413784.d</institution-id><institution/><institution>Service de R&#x000e9;animation m&#x000e9;dicale, H&#x000f4;pitaux universitaires Paris-Sud, Assistance Publique-H&#x000f4;pitaux de Paris, H&#x000f4;pital de Bic&#x000ea;tre, </institution></institution-wrap>78 rue du G&#x000e9;n&#x000e9;ral Leclerc, Le Kremlin-Bic&#x000ea;tre, F-94270 France </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>21</volume><elocation-id>133</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Since the first publication of the Surviving Sepsis Campaign (SSC) guidelines [<xref ref-type="bibr" rid="CR1">1</xref>], a corpus of contradictory evidence as well as physiological objections on critical aspects of the hemodynamic resuscitation have emerged over time [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. The most recent SSC guidelines [<xref ref-type="bibr" rid="CR5">5</xref>] have radically moved from a structured bundle approach to extremely broad recommendations, leaving fundamental pieces of care without clear-cut guidance for attending physicians, especially for monitoring and treatment. We wish to critically analyze potential negative consequences of some SSC&#x02019;s hemodynamic recommendations and to discuss neglected areas.</p><sec id="Sec1"><title>Fluids</title><p>It is now recommended to infuse at least 30&#x000a0;mL/kg of IV crystalloids within the first 3&#x000a0;h of resuscitation of sepsis-induced hypoperfusion. We are concerned by both the predefined volume and timeframe. First, all septic patients do not exhibit the same degree of hypovolemia. For instance, abdominal sepsis inducing massive internal or external fluid losses is generally not equivalent to community-acquired pneumonia in terms of volume deficit. Deliberate administration of 30&#x000a0;mL/kg of fluids in patients with pneumonia with cardiovascular comorbidities might eventually result in pulmonary edema and hasten the need for mechanical ventilation. Initial fluid resuscitation should be individualized according to several elements, including clinical signs of hypovolemia, body temperature, pulse pressure, age, comorbidities, and sepsis origin. If hypovolemia is assumed to be a major component of hypoperfusion, fluids should be infused as a rapid fluid bolus to increase mean systemic filling pressure, venous return, and stroke volume [<xref ref-type="bibr" rid="CR6">6</xref>]. The same amount of fluids infused in 3&#x000a0;h cannot have a measurable effect on systemic blood flow in this context. Second, early reassessment of hemodynamics is a fundamental aspect of management of patients with shock [<xref ref-type="bibr" rid="CR7">7</xref>]. It is unreasonable to wait for 3&#x000a0;h&#x02014;as it is suggested in the SSC guidelines [<xref ref-type="bibr" rid="CR5">5</xref>]&#x02014;before reassessing the effects of the initial fluid therapy.</p></sec><sec id="Sec2"><title>Vasopressors</title><p>From the last version of the SSC publication [<xref ref-type="bibr" rid="CR5">5</xref>], it is unclear when norepinephrine should be initiated. The reader could understand that the decision should be made only at the time of the first reassessment (3&#x000a0;h). One major characteristic of septic shock is vasoplegia, where the need of a vasopressor is mandatory since fluid resuscitation alone cannot restore vascular tone and thus cannot completely correct profound hypotension [<xref ref-type="bibr" rid="CR8">8</xref>], which is an event associated with mortality [<xref ref-type="bibr" rid="CR9">9</xref>]. In addition, sepsis-induced vasoplegia results in a dramatic fall in diastolic arterial pressure (DAP), which represents the upstream pressure for perfusion of the left ventricle. A low DAP, especially in the context of tachycardia, can be an easy bedside tool to identify patients who need early initiation of a vasopressor. This was mentioned in the previous publication of the SCC [<xref ref-type="bibr" rid="CR10">10</xref>] but disappeared inexplicably in the most recent one [<xref ref-type="bibr" rid="CR5">5</xref>]. Early initiation of a vasopressor not only can rapidly correct hypotension in case of low vascular tone but also can avoid harmful fluid overload.</p></sec><sec id="Sec3"><title>Perfusion monitoring</title><p>After several recent negative trials testing the use of central venous oxygen saturation (ScvO<sub>2</sub>) as a target for early resuscitation of septic shock [<xref ref-type="bibr" rid="CR4">4</xref>], the SSC has abandoned its initial recommendation to include ScvO<sub>2</sub> as part of standard monitoring. This could lead to a loss of confidence in the value of multimodal perfusion monitoring to assess the adequacy of systemic blood flow in relation to oxygen demand. This is profoundly regrettable since a low ScvO<sub>2</sub> generally reveals an inadequate cardiac output and suggests the presence of a hypoperfusion context in case of a persistent hyperlactatemia (&#x0201c;flow-sensitive&#x0201d; hyperlactatemia) [<xref ref-type="bibr" rid="CR11">11</xref>].</p></sec><sec id="Sec4"><title>Lactate normalization as a resuscitation target</title><p>Normalization of lactate is recommended by the SSC as a resuscitation goal since it is assumed that tissue hypoxia is the main source of lactate production. However, there are several unresolved concerns about the role of lactate as an appropriate resuscitation target. First, besides hypoperfusion, adrenergic-driven aerobic lactate production and impaired hepatic lactate clearance have been suggested as important contributors to persistent hyperlactatemia [<xref ref-type="bibr" rid="CR12">12</xref>]. Since non-hypoperfusion-related causes of hyperlactatemia might predominate in an unknown number of patients, aiming at strictly normalizing lactate might lead to excessive resuscitation with inherent fluid and vasopressor overload, and eventually to increased morbidity and mortality. Second, the dynamics of recovery of blood lactate exhibits a complex pattern and might not, therefore, be the best tool for real-time assessment of the effect of hemodynamic resuscitation [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. A recent study by Hernandez et al. [<xref ref-type="bibr" rid="CR14">14</xref>] demonstrated that only 50% of septic shock survivors normalize lactate during the first 24&#x000a0;h of management. Variables such as ScvO<sub>2</sub>, central venous-arterial PCO<sub>2</sub> gradient (P(cv-a)CO<sub>2</sub>), and peripheral (skin) perfusion markers exhibit a very fast normalization rate in relation to systemic flow optimization, whereas blood lactate shows a biphasic response with an initial rapid improvement in parallel with the above-mentioned variables, followed by a much slower trend thereafter [<xref ref-type="bibr" rid="CR14">14</xref>]. Thus, a concomitant low ScvO<sub>2</sub>, or high P(cv-a)CO<sub>2</sub>, or abnormal peripheral perfusion defines a &#x0201c;hypoperfusion context&#x0201d; in which increasing systemic blood flow may contribute to blood lactate decrease. Applying these criteria to septic hyperlactatemic patients in a recent proof-of-concept study clearly differentiated two subpopulations of patients exhibiting markedly different risk of morbidity and mortality [<xref ref-type="bibr" rid="CR11">11</xref>].</p></sec><sec id="Sec5"><title>Conclusions</title><p>Important knowledge on the pathophysiology of septic shock has been built up over decades of experimental and clinical research. Translation of these scientific foundations into clinical practice has, however, been slow and erratic. For such a condition with a mortality risk of at least 30&#x02013;40%, we should expect the rationale of consensus recommendations to be firmly grounded on pathophysiology. Our opinion is that some of the recent SSC&#x02019;s hemodynamic recommendations move far away from this objective and might not constitute a valuable contribution to improve septic shock morbidity or mortality.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DAP</term><def><p>Diastolic arterial pressure</p></def></def-item><def-item><term>IV</term><def><p>Intravenous</p></def></def-item><def-item><term>P(cv-a)CO<sub>2</sub></term><def><p>Carbon dioxide pressure difference between central vein blood and arterial blood</p></def></def-item><def-item><term>PCO<sub>2</sub></term><def><p>Carbon dioxide partial pressure</p></def></def-item><def-item><term>ScvO<sub>2</sub></term><def><p>Central venous oxygen saturation</p></def></def-item><def-item><term>SSC</term><def><p>Surviving Sepsis Campaign</p></def></def-item></def-list></glossary><ack><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p>Not applicable.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec id="FPar3"><title>Author&#x02019;s contribution</title><p>GH and JLT equally contributed to draft the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethical approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Carlet</surname><given-names>JM</given-names></name><name><surname>Masur</surname><given-names>H</given-names></name><name><surname>Gerlach</surname><given-names>H</given-names></name><name><surname>Calandra</surname><given-names>T</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock</article-title><source>Crit Care Med.</source><year>2004</year><volume>32</volume><fpage>858</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000117317.18092.E4</pub-id><?supplied-pmid 15090974?><pub-id pub-id-type="pmid">15090974</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finfer</surname><given-names>S</given-names></name></person-group><article-title>The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed</article-title><source>Crit Care Med.</source><year>2010</year><volume>38</volume><fpage>683</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3181cc5302</pub-id><?supplied-pmid 20083922?><pub-id pub-id-type="pmid">20083922</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marik</surname><given-names>PE</given-names></name></person-group><article-title>Surviving sepsis: going beyond the guidelines</article-title><source>Ann Intensive Care.</source><year>2011</year><volume>1</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/2110-5820-1-17</pub-id><?supplied-pmid 21906348?><pub-id pub-id-type="pmid">21906348</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">PRISM Investigators. Early, goal-directed therapy for septic shock--a patient-level meta-analysis. N Engl J Med. 2017 [Epub ahead of print].</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>LE</given-names></name><name><surname>Alhazzani</surname><given-names>W</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Ferrer</surname><given-names>R</given-names></name><etal/></person-group><article-title>Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016</article-title><source>Intensive Care Med.</source><year>2017</year><volume>43</volume><fpage>304</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s00134-017-4683-6</pub-id><?supplied-pmid 28101605?><pub-id pub-id-type="pmid">28101605</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carsetti</surname><given-names>A</given-names></name><name><surname>Cecconi</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name></person-group><article-title>Fluid bolus therapy: monitoring and predicting fluid responsiveness</article-title><source>Curr Opin Crit Care.</source><year>2015</year><volume>21</volume><fpage>388</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1097/MCC.0000000000000240</pub-id><?supplied-pmid 26348418?><pub-id pub-id-type="pmid">26348418</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecconi</surname><given-names>M</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Beale</surname><given-names>R</given-names></name><name><surname>Bakker</surname><given-names>J</given-names></name><name><surname>Hofer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine</article-title><source>Intensive Care Med</source><year>2014</year><volume>40</volume><fpage>1795</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1007/s00134-014-3525-z</pub-id><?supplied-pmid 25392034?><pub-id pub-id-type="pmid">25392034</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamzaoui</surname><given-names>O</given-names></name><name><surname>Georger</surname><given-names>JF</given-names></name><name><surname>Monnet</surname><given-names>X</given-names></name><name><surname>Ksouri</surname><given-names>H</given-names></name><name><surname>Maizel</surname><given-names>J</given-names></name><name><surname>Richard</surname><given-names>C</given-names></name><etal/></person-group><article-title>Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension</article-title><source>Crit Care.</source><year>2010</year><volume>14</volume><fpage>R142</fpage><pub-id pub-id-type="doi">10.1186/cc9207</pub-id><?supplied-pmid 20670424?><pub-id pub-id-type="pmid">20670424</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varpula</surname><given-names>M</given-names></name><name><surname>Tallgren</surname><given-names>M</given-names></name><name><surname>Saukkonen</surname><given-names>K</given-names></name><name><surname>Voipio-Pulkki</surname><given-names>LM</given-names></name><name><surname>Pettil&#x000e4;</surname><given-names>V</given-names></name></person-group><article-title>Hemodynamic variables related to outcome in septic shock</article-title><source>Intensive Care Med.</source><year>2005</year><volume>31</volume><fpage>1066</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1007/s00134-005-2688-z</pub-id><?supplied-pmid 15973520?><pub-id pub-id-type="pmid">15973520</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>Gerlach</surname><given-names>H</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012</article-title><source>Intensive Care Med.</source><year>2013</year><volume>39</volume><fpage>165</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s00134-012-2769-8</pub-id><?supplied-pmid 23361625?><pub-id pub-id-type="pmid">23361625</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alegr&#x000ed;a</surname><given-names>L</given-names></name><name><surname>Vera</surname><given-names>M</given-names></name><name><surname>Dreyse</surname><given-names>J</given-names></name><name><surname>Castro</surname><given-names>R</given-names></name><name><surname>Carpio</surname><given-names>D</given-names></name><name><surname>Henriquez</surname><given-names>C</given-names></name><etal/></person-group><article-title>A hypoperfusion context may aid to interpret hyperlactatemia in sepsis-3 septic shock patients: a proof-of-concept study</article-title><source>Ann Intensive Care.</source><year>2017</year><volume>7</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/s13613-017-0253-x</pub-id><?supplied-pmid 28281216?><pub-id pub-id-type="pmid">28281216</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>G</given-names></name><name><surname>Bruhn</surname><given-names>A</given-names></name><name><surname>Castro</surname><given-names>R</given-names></name><name><surname>Regueira</surname><given-names>T</given-names></name></person-group><article-title>The holistic view on perfusion monitoring in septic shock</article-title><source>Curr Opinion Crit Care.</source><year>2012</year><volume>18</volume><fpage>280</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/MCC.0b013e3283532c08</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Quintairos</surname><given-names>E</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Couto</surname><given-names>L</given-names><suffix>Jr</suffix></name><name><surname>Taccone</surname><given-names>FS</given-names></name></person-group><article-title>The value of blood lactate kinetics in critically ill patients: a systematic review</article-title><source>Crit Care.</source><year>2016</year><volume>20</volume><fpage>257</fpage><pub-id pub-id-type="doi">10.1186/s13054-016-1403-5</pub-id><?supplied-pmid 27520452?><pub-id pub-id-type="pmid">27520452</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>G</given-names></name><name><surname>Luengo</surname><given-names>C</given-names></name><name><surname>Bruhn</surname><given-names>A</given-names></name><name><surname>Kattan</surname><given-names>E</given-names></name><name><surname>Friedman</surname><given-names>G</given-names></name><name><surname>Ospina-Tascon</surname><given-names>GA</given-names></name><etal/></person-group><article-title>When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring</article-title><source>Ann Intensive Care.</source><year>2014</year><volume>4</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1186/s13613-014-0030-z</pub-id><?supplied-pmid 25593746?><pub-id pub-id-type="pmid">25593746</pub-id></element-citation></ref></ref-list></back></article>